Literature DB >> 18576676

Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.

Mahesh L Patil1, Min Zhang, Seema Betigeri, Oleh Taratula, Huixin He, Tamara Minko.   

Abstract

A novel internally quaternized and surface-acetylated poly(amidoamine) generation four dendrimer (QPAMAM-NHAc) was synthesized and evaluated for intracellular delivery of siRNA. The proposed dendrimer as a nanocarrier possesses the following advantages: (1) modified neutral surface of the dendrimer for low cytotoxicity and enhanced cellular internalization; (2) existence of cationic charges inside the dendrimer (not on the outer surface) resulting in highly organized compact nanoparticles, which can potentially protect nucleic acids from degradation. The properties of this dendrimer were compared with PAMAM-NH 2 dendrimer, possessing surface charges, and with an internally quaternized charged and hydroxyl-terminated QPAMAM-OH dendrimer. Atomic force microscopy studies revealed that internally charged and surface neutral dendrimers, QPAMAM-OH and QPAMAM-NHAc, formed well-condensed, spherical particles (polyplexes) with siRNA, while PAMAM-NH 2 resulted in the formation of nanofibers. The modification of surface amine groups to amide significantly reduced cytotoxicity of dendrimers with QPAMAM-NHAc dendrimer showing the lowest toxicity. Confocal microscopy demonstrated enhanced cellular uptake and homogeneous intracellular distribution of siRNA delivered by the proposed QPAMAM-NHAc nanocarrier. The results clearly demonstrated distinct advantages of developed QPAMAM-NHAc/siRNA polyplexes over the existing nucleic acid dendrimeric carriers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18576676     DOI: 10.1021/bc8000722

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  52 in total

Review 1.  Delivery of siRNA therapeutics: barriers and carriers.

Authors:  Jie Wang; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2010-06-11       Impact factor: 4.009

2.  Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.

Authors:  Olivia M Merkel; Meredith A Mintzer; Damiano Librizzi; Olga Samsonova; Tanja Dicke; Brian Sproat; Holger Garn; Peter J Barth; Eric E Simanek; Thomas Kissel
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 3.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

4.  Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core.

Authors:  Yue Zhang; Chenguang Zhou; Kwang Joo Kwak; Xinmei Wang; Bryant Yung; L James Lee; Yanming Wang; Peng George Wang; Robert J Lee
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

Review 5.  Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2011-07

Review 6.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

7.  Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.

Authors:  Oleh Taratula; Olga B Garbuzenko; Paul Kirkpatrick; Ipsit Pandya; Ronak Savla; Vitaly P Pozharov; Huixin He; Tamara Minko
Journal:  J Control Release       Date:  2009-06-28       Impact factor: 9.776

Review 8.  Particle-based technologies for osteoarthritis detection and therapy.

Authors:  Taylor E Kavanaugh; Thomas A Werfel; Hongsik Cho; Karen A Hasty; Craig L Duvall
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

9.  PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Bioconjug Chem       Date:  2009-09-23       Impact factor: 4.774

10.  Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery.

Authors:  Jongjin Jung; Aniruddh Solanki; Kevin A Memoli; Ken-ichiro Kamei; Hiyun Kim; Michael A Drahl; Lawrence J Williams; Hsian-Rong Tseng; KiBum Lee
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.